Cargando…

IL-6 and Akt are involved in muscular pathogenesis in myasthenia gravis

INTRODUCTION: Anti-acetylcholine receptor (AChR) autoantibodies target muscles in spontaneous human myasthenia gravis (MG) and its induced experimental autoimmune model MG (EAMG). The aim of this study was to identify novel functional mechanisms occurring in the muscle pathology of myasthenia. RESUL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maurer, Marie, Bougoin, Sylvain, Feferman, Tali, Frenkian, Mélinée, Bismuth, Jacky, Mouly, Vincent, Clairac, Geraldine, Tzartos, Socrates, Fadel, Elie, Eymard, Bruno, Fuchs, Sara, Souroujon, Miriam C, Berrih-Aknin, Sonia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308930/ https://www.ncbi.nlm.nih.gov/pubmed/25627031 http://dx.doi.org/10.1186/s40478-014-0179-6

Ejemplares similares

Autoimmune Thyroiditis and Myasthenia Gravis
por: Lopomo, Angela, et al.
Publicado: (2017)

Comparative Analysis of Thymic and Blood Treg in Myasthenia Gravis: Thymic Epithelial Cells Contribute to Thymic Immunoregulatory Defects
por: Truffault, Frédérique, et al.
Publicado: (2020)

Editorial: Advances in Autoimmune Myasthenia Gravis
por: Punga, Anna Rostedt, et al.
Publicado: (2020)

Myasthenia Gravis: An Acquired Interferonopathy?
por: Payet, Cloé A., et al.
Publicado: (2022)

The Muscle Is Not a Passive Target in Myasthenia Gravis
por: Vilquin, Jean-Thomas, et al.
Publicado: (2019)

Myasthenia Gravis: Autoantibody Specificities and Their Role in MG Management
por: Lazaridis, Konstantinos, et al.
Publicado: (2020)

Causes and Consequences of miR-150-5p Dysregulation in Myasthenia Gravis
por: Cron, Mélanie A., et al.
Publicado: (2019)

Decreased expression of miR-29 family associated with autoimmune myasthenia gravis
por: Cron, Mélanie A., et al.
Publicado: (2020)

Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics
por: Lazaridis, Konstantinos, et al.
Publicado: (2020)

Altered expression of fragile X mental retardation-1 (FMR1) in the thymus in autoimmune myasthenia gravis
por: Thomas, Scott, et al.
Publicado: (2021)

Novel CXCL13 transgenic mouse: inflammation drives pathogenic effect of CXCL13 in experimental myasthenia gravis
por: Weiss, Julia Miriam, et al.
Publicado: (2016)

Recent Advances in Genetic Predisposition of Myasthenia Gravis
por: Zagoriti, Zoi, et al.
Publicado: (2013)

Regulatory B cells in myasthenia gravis are differentially affected by therapies
por: Yilmaz, Vuslat, et al.
Publicado: (2018)

Single-cell mass cytometry on peripheral cells in Myasthenia Gravis identifies dysregulation of innate immune cells
por: Verdier, Julien, et al.
Publicado: (2023)

The benefits and tolerance of exercise in myasthenia gravis (MGEX): study protocol for a randomised controlled trial
por: Birnbaum, Simone, et al.
Publicado: (2018)

Use of Toll-Like Receptor Agonists to Induce Ectopic Lymphoid Structures in Myasthenia Gravis Mouse Models
por: Robinet, Marieke, et al.
Publicado: (2017)

Circulating miRNAs in myasthenia gravis: miR-150-5p as a new potential biomarker
por: Punga, Tanel, et al.
Publicado: (2014)

Direct Proof of the In Vivo Pathogenic Role of the AChR Autoantibodies from Myasthenia Gravis Patients
por: Kordas, Gregory, et al.
Publicado: (2014)

Genetics of Myasthenia Gravis: A Case-Control Association Study in the Hellenic Population
por: Zagoriti, Zoi, et al.
Publicado: (2012)

Inflammation and Epstein-Barr Virus Infection Are Common Features of Myasthenia Gravis Thymus: Possible Roles in Pathogenesis
por: Cavalcante, Paola, et al.
Publicado: (2011)

Blocking interleukin-23 ameliorates neuromuscular and thymic defects in myasthenia gravis
por: Villegas, José A., et al.
Publicado: (2023)

VAV1 and BAFF, via NFκB pathway, are genetic risk factors for myasthenia gravis
por: Avidan, Nili, et al.
Publicado: (2014)

Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease
por: Vakrakou, Aigli G., et al.
Publicado: (2023)

A Striational Muscle Antigen and Myasthenia Gravis-Associated Thymomas Share an Acetylcholine-Receptor Epitope
por: Marx, Alexander, et al.
Publicado: (1992)

Fatigue in myasthenia gravis: is it more than muscular weakness?
por: Elsais, Ahmed, et al.
Publicado: (2013)

Marathons and myasthenia gravis: a case report
por: Birnbaum, Simone, et al.
Publicado: (2018)

Immunological and Structural Characterization of Titin Main Immunogenic Region; I110 Domain Is the Target of Titin Antibodies in Myasthenia Gravis
por: Stergiou, Christos, et al.
Publicado: (2023)

Common Denominators in the Immunobiology of IgG4 Autoimmune Diseases: What Do Glomerulonephritis, Pemphigus Vulgaris, Myasthenia Gravis, Thrombotic Thrombocytopenic Purpura and Autoimmune Encephalitis Have in Common?
por: Koneczny, Inga, et al.
Publicado: (2021)

A rare case of facioscapulohumeral muscular dystrophy and myasthenia gravis
por: Asadollahi, Marjan, et al.
Publicado: (2012)

Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK
por: Yilmaz, Vuslat, et al.
Publicado: (2015)

Human thymus medullary epithelial cells promote regulatory T-cell generation by stimulating interleukin-2 production via ICOS ligand
por: Nazzal, D, et al.
Publicado: (2014)

Myasthenia gravis
por: Juel, Vern C, et al.
Publicado: (2007)

Myasthenia Gravis
por: Aarli, Johan A., et al.
Publicado: (2011)

Myasthenia Gravis
Publicado: (1905)

Myasthenia Gravis
por: Wilson, Andrew
Publicado: (1952)

Myasthenia Gravis
por: Bramwell, Edwin
Publicado: (1901)

Patient-reported impact of myasthenia gravis in the real world: protocol for a digital observational study (MyRealWorld MG)
por: Berrih-Aknin, Sonia, et al.
Publicado: (2021)

A Recombinant Acetylcholine Receptor α1 Subunit Extracellular Domain Is a Promising New Drug Candidate for Treatment Of Myasthenia Gravis
por: Lazaridis, Konstantinos, et al.
Publicado: (2022)

MYASTHENIA GRAVIS CRISIS TRIGGERED BY COVID-19
por: Fares, Elie, et al.
Publicado: (2020)

Standardization of the experimental autoimmune myasthenia gravis (EAMG) model by immunization of rats with Torpedo californica acetylcholine receptors — Recommendations for methods and experimental designs
por: Losen, Mario, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6o097pikqns98p745uhh60g8q5